Is Sanofi (SNY) One of the Best Healthcare Stocks Under $50 to Invest In?

Group 1 - Sanofi is recognized as one of the best healthcare stocks under $50, with a Hold rating from Kepler Capital and a price target of €85 [1] - The company announced a share buyback program of €1 billion to be executed by the end of 2026, with a mandate established on February 2 [1] - Sanofi reported positive results from the LEAP2MONO phase 3 study, where its investigational drug Venglustat met primary and three out of four key secondary endpoints for treating type 3 Gaucher disease [2] Group 2 - Sanofi operates in three segments: Pharmaceuticals, Consumer Healthcare, and Vaccines, focusing on research, production, and distribution of pharmaceutical products [3]